These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 34201091)
1. A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes. Iyamu ID; Al-Hamashi AA; Huang R Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34201091 [TBL] [Abstract][Full Text] [Related]
2. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization. Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763 [TBL] [Abstract][Full Text] [Related]
3. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases. Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328 [TBL] [Abstract][Full Text] [Related]
4. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors. Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828 [TBL] [Abstract][Full Text] [Related]
5. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1. Osborne T; Roska RL; Rajski SR; Thompson PR J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5. Al-Hamashi AA; Chen D; Deng Y; Dong G; Huang R Acta Pharm Sin B; 2021 Sep; 11(9):2709-2718. PubMed ID: 34589391 [TBL] [Abstract][Full Text] [Related]
7. Activity-based protein profiling of protein arginine methyltransferase 1. Obianyo O; Causey CP; Jones JE; Thompson PR ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253 [TBL] [Abstract][Full Text] [Related]
8. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. Osborne TC; Obianyo O; Zhang X; Cheng X; Thompson PR Biochemistry; 2007 Nov; 46(46):13370-81. PubMed ID: 17960915 [TBL] [Abstract][Full Text] [Related]
9. Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1. Hendrickson-Rebizant T; Sudhakar SRN; Rowley MJ; Frankel A; Davie JR; Lakowski TM J Med Chem; 2024 Sep; 67(18):15931-15946. PubMed ID: 39250434 [TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4). Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor. Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386 [TBL] [Abstract][Full Text] [Related]
12. Peptidic transition state analogues as PRMT inhibitors. Zhang Y; van Haren MJ; Martin NI Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210 [TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1. Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734 [TBL] [Abstract][Full Text] [Related]
14. Development of Potent Type I Protein Arginine Methyltransferase (PRMT) Inhibitors of Leukemia Cell Proliferation. Wang C; Jiang H; Jin J; Xie Y; Chen Z; Zhang H; Lian F; Liu YC; Zhang C; Ding H; Chen S; Zhang N; Zhang Y; Jiang H; Chen K; Ye F; Yao Z; Luo C J Med Chem; 2017 Nov; 60(21):8888-8905. PubMed ID: 29019697 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6. Shen Y; Szewczyk MM; Eram MS; Smil D; Kaniskan HÜ; de Freitas RF; Senisterra G; Li F; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J J Med Chem; 2016 Oct; 59(19):9124-9139. PubMed ID: 27584694 [TBL] [Abstract][Full Text] [Related]
16. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach. Bhattacharya D; Shi Ming Li A; Paul B; Ghosh Dastidar U; Santhakumar V; Sarkar D; Chau I; Li F; Ghosh T; Vedadi M; Talukdar A Eur J Med Chem; 2023 Nov; 260():115713. PubMed ID: 37597437 [TBL] [Abstract][Full Text] [Related]
17. Investigating the binding preferences of small molecule inhibitors of human protein arginine methyltransferase 1 using molecular modelling. Hong W; Li J; Laughton CA; Yap LF; Paterson IC; Wang H J Mol Graph Model; 2014 Jun; 51():193-202. PubMed ID: 24937176 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory study of protein arginine methyltransferase 1 using a fluorescent approach. Feng Y; Xie N; Wu J; Yang C; Zheng YG Biochem Biophys Res Commun; 2009 Feb; 379(2):567-72. PubMed ID: 19121292 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites. van Haren M; van Ufford LQ; Moret EE; Martin NI Org Biomol Chem; 2015 Jan; 13(2):549-60. PubMed ID: 25380215 [TBL] [Abstract][Full Text] [Related]
20. Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation. Hu H; Owens EA; Su H; Yan L; Levitz A; Zhao X; Henary M; Zheng YG J Med Chem; 2015 Feb; 58(3):1228-43. PubMed ID: 25559100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]